Back to Search Start Over

Clinical outcomes of AML patients treated with Azacitidine in Portugal: A retrospective multicenter study

Authors :
António Almeida
Ana Rita Ferreira
Maria João Costa
Sofia Silva
Khalil Alnajjar
Isabel Bogalho
Francesca Pierdomenico
Susana Esteves
Mafalda Alpoim
Gil Braz
Emilia Cortesão
Ricardo Pinto
Source :
Leukemia Research Reports, Vol 7, Iss C, Pp 6-10 (2017)
Publication Year :
2017
Publisher :
Elsevier, 2017.

Abstract

Retrospective data was collected from 77 elderly acute myeloid leukemia (AML) patients treated with Azacitidine (AZA) and 50 elderly AML patients treated with intensive chemotherapy (IC) from 4 Portuguese Hospitals. Median OS was 10.6 months in those receiving AZA as 1st line. Response (overall response rate 44%) had a significant impact on overall survival (p=

Details

Language :
English
ISSN :
22130489
Volume :
7
Issue :
C
Database :
Directory of Open Access Journals
Journal :
Leukemia Research Reports
Publication Type :
Academic Journal
Accession number :
edsdoj.45099a3bebe4dbb83a8c4ede35d88f8
Document Type :
article
Full Text :
https://doi.org/10.1016/j.lrr.2016.12.002